189 related articles for article (PubMed ID: 20195262)
1. Immunology and gene therapy: shoulder to shoulder into the fray.
Smerdou C; Ochoa C; Quetglas JI; Fontanellas A; Gonzalez-Aseguinolaza G; Vile RG; Melero I
Mol Ther; 2010 Mar; 18(3):456-9. PubMed ID: 20195262
[No Abstract] [Full Text] [Related]
2. Cabo II: immunology and gene therapy.
Second Cabo Gene Therapy Working Group
Mol Ther; 2002 May; 5(5 Pt 1):486-91. PubMed ID: 11991738
[No Abstract] [Full Text] [Related]
3. The current status of clinical gene therapy.
Anderson WF
Hum Gene Ther; 2002 Jul; 13(11):1261-2. PubMed ID: 12162809
[No Abstract] [Full Text] [Related]
4. A look to future directions in gene therapy research for monogenic diseases.
Porteus MH; Connelly JP; Pruett SM
PLoS Genet; 2006 Sep; 2(9):e133. PubMed ID: 17009872
[TBL] [Abstract][Full Text] [Related]
5. American Society of Gene Therapy--tenth annual meeting.
Romano G; Giordano A
IDrugs; 2007 Aug; 10(8):534-7. PubMed ID: 17665326
[No Abstract] [Full Text] [Related]
6. International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers.
Guinn BA; Norris JS; Huang L; Farzaneh F; Kasahara N; Deisseroth AB
Cancer Immunol Immunother; 2006 Nov; 55(11):1406-11. PubMed ID: 16783577
[No Abstract] [Full Text] [Related]
7. Science, medicine, and the future. Gene therapy.
Russell SJ
BMJ; 1997 Nov; 315(7118):1289-92. PubMed ID: 9390059
[No Abstract] [Full Text] [Related]
8. Clinical applications of recombinant virus-based cancer immunotherapy.
Adamina M; Daetwiler S; Rosenthal R; Zajac P
Expert Opin Biol Ther; 2005 Sep; 5(9):1211-24. PubMed ID: 16120051
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy. Is the future here yet?
Yaron Y; Kramer RL; Johnson MP; Evans MI
Obstet Gynecol Clin North Am; 1997 Mar; 24(1):179-99. PubMed ID: 9086525
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell Genomics: Approaches and Utility in Immunology.
Neu KE; Tang Q; Wilson PC; Khan AA
Trends Immunol; 2017 Feb; 38(2):140-149. PubMed ID: 28094102
[TBL] [Abstract][Full Text] [Related]
11. Viral vectors in cancer immunotherapy: which vector for which strategy?
Collins SA; Guinn BA; Harrison PT; Scallan MF; O'Sullivan GC; Tangney M
Curr Gene Ther; 2008 Apr; 8(2):66-78. PubMed ID: 18393828
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy: breaking the barriers to harvest the crop.
Pardoll D; Allison J
Nat Med; 2004 Sep; 10(9):887-92. PubMed ID: 15340404
[TBL] [Abstract][Full Text] [Related]
13. Editorial: keeping track of an expanding subject--recent trends in immunology and their clinical implications.
Patejdl R; Mix E; Zettl UK
Curr Pharm Des; 2012; 18(29):4441-2. PubMed ID: 22873750
[No Abstract] [Full Text] [Related]
14. [Immunology--risk management in the body].
Kabelitz D
Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1563-5. PubMed ID: 15965863
[No Abstract] [Full Text] [Related]
15. Advances in the techniques and methodologies of cancer gene therapy.
Sun W; Shi Q; Zhang H; Yang K; Ke Y; Wang Y; Qiao L
Discov Med; 2019 Jan; 27(146):45-55. PubMed ID: 30721651
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceuticals and gene vectors opening new avenues in cancer immune therapy.
Sami H; Ogris M
Ther Deliv; 2016 Jul; 7(7):419-22. PubMed ID: 27403627
[No Abstract] [Full Text] [Related]
17. [New immunological concepts in oncology].
Versicherungsmedizin; 2013 Sep; 65(3):156-7. PubMed ID: 24137899
[No Abstract] [Full Text] [Related]
18. Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles.
Loskog A
Viruses; 2015 Nov; 7(11):5780-91. PubMed ID: 26561829
[TBL] [Abstract][Full Text] [Related]
19. Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans.
Cerullo V; Koski A; Vähä-Koskela M; Hemminki A
Adv Cancer Res; 2012; 115():265-318. PubMed ID: 23021247
[TBL] [Abstract][Full Text] [Related]
20. 9th American Society of Gene Therapy annual meeting.
Tan PH
Expert Opin Biol Ther; 2006 Aug; 6(8):839-42. PubMed ID: 16856805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
